Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
P 3 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT03296943Phase 3CompletedPrimary

Efficacy of Inhalation of Essential Oil on the Reduction of Inhalants Craving

Showing all 1 trials

Research Network

Activity Timeline